Clinical Trial Update: Gluten Challenge Study in Celiac Disease Participants (MK-0000-402) [EARLY_Phase 1]

View source ↗

Summary

A Phase 1 gluten challenge study in participants with celiac disease has completed and results were posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Celiac Disease | EARLY_Phase 1 | Status: COMPLETED | Results posted: 2023-03-06